Antibiotics Active Pharmaceutical Ingredient Market - Global Outlook and Forecast 2021-2027

March 2021 | 91 pages | ID: AA3F2E9B9C66EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Antibiotics Active Pharmaceutical Ingredient in Global, including the following market information:

Global Antibiotics Active Pharmaceutical Ingredient Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Antibiotics Active Pharmaceutical Ingredient market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibiotics Active Pharmaceutical Ingredient companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibiotics Active Pharmaceutical Ingredient Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Antibiotics Active Pharmaceutical Ingredient Market Segment Percentages, By Type, 2020 (%)

• Penicillin Antibiotics
• Cephalosporins
• Carbapenem Antibiotics

China Antibiotics Active Pharmaceutical Ingredient Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Antibiotics Active Pharmaceutical Ingredient Market Segment Percentages, By Application, 2020 (%)

• Pharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Contract Development & Manufacturing Organizations (CDMOs)

Global Antibiotics Active Pharmaceutical Ingredient Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Antibiotics Active Pharmaceutical Ingredient Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Antibiotics Active Pharmaceutical Ingredient Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Antibiotics Active Pharmaceutical Ingredient Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Sandoz International
• Centrient Pharmaceuticals
• CordenPharma International
• ACS DOBFAR
• Nanjing Dorra Pharmaceutical Technology
• DAEWOONG PHARMACEUTICAL
• Parabolic Drugs
• Penam Laboratories
• ASIATIC DRUGS & PHARMACEUTICALS
• Fresenius Kabi
• The United Laboratories International Holdings
• Aurobindo Pharma Limited
• Unimark Remedies
• Savior Lifetec

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antibiotics Active Pharmaceutical Ingredient Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antibiotics Active Pharmaceutical Ingredient Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIBIOTICS ACTIVE PHARMACEUTICAL INGREDIENT OVERALL MARKET SIZE

2.1 Global Antibiotics Active Pharmaceutical Ingredient Market Size: 2021 VS 2027
2.2 Global Antibiotics Active Pharmaceutical Ingredient Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antibiotics Active Pharmaceutical Ingredient Players in Global Market
3.2 Top Global Antibiotics Active Pharmaceutical Ingredient Companies Ranked by Revenue
3.3 Global Antibiotics Active Pharmaceutical Ingredient Revenue by Companies
3.4 Top 3 and Top 5 Antibiotics Active Pharmaceutical Ingredient Companies in Global Market, by Revenue in 2020
3.5 Global Companies Antibiotics Active Pharmaceutical Ingredient Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antibiotics Active Pharmaceutical Ingredient Players in Global Market
  3.6.1 List of Global Tier 1 Antibiotics Active Pharmaceutical Ingredient Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antibiotics Active Pharmaceutical Ingredient Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antibiotics Active Pharmaceutical Ingredient Market Size Markets, 2021 & 2027
  4.1.2 Penicillin Antibiotics
  4.1.3 Cephalosporins
  4.1.4 Carbapenem Antibiotics
4.2 By Type - Global Antibiotics Active Pharmaceutical Ingredient Revenue & Forecasts
  4.2.1 By Type - Global Antibiotics Active Pharmaceutical Ingredient Revenue, 2016-2021
  4.2.2 By Type - Global Antibiotics Active Pharmaceutical Ingredient Revenue, 2022-2027
  4.2.3 By Type - Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antibiotics Active Pharmaceutical Ingredient Market Size, 2021 & 2027
  5.1.2 Pharmaceutical Companies
  5.1.3 Contract Manufacturing Organizations (CMOs)
  5.1.4 Contract Development & Manufacturing Organizations (CDMOs)
5.2 By Application - Global Antibiotics Active Pharmaceutical Ingredient Revenue & Forecasts
  5.2.1 By Application - Global Antibiotics Active Pharmaceutical Ingredient Revenue, 2016-2021
  5.2.2 By Application - Global Antibiotics Active Pharmaceutical Ingredient Revenue, 2022-2027
  5.2.3 By Application - Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Antibiotics Active Pharmaceutical Ingredient Market Size, 2021 & 2027
6.2 By Region - Global Antibiotics Active Pharmaceutical Ingredient Revenue & Forecasts
  6.2.1 By Region - Global Antibiotics Active Pharmaceutical Ingredient Revenue, 2016-2021
  6.2.2 By Region - Global Antibiotics Active Pharmaceutical Ingredient Revenue, 2022-2027
  6.2.3 By Region - Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Antibiotics Active Pharmaceutical Ingredient Revenue, 2016-2027
  6.3.2 US Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.3.3 Canada Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.3.4 Mexico Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Antibiotics Active Pharmaceutical Ingredient Revenue, 2016-2027
  6.4.2 Germany Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.4.3 France Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.4.4 U.K. Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.4.5 Italy Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.4.6 Russia Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.4.7 Nordic Countries Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.4.8 Benelux Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Antibiotics Active Pharmaceutical Ingredient Revenue, 2016-2027
  6.5.2 China Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.5.3 Japan Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.5.4 South Korea Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.5.5 Southeast Asia Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.5.6 India Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Antibiotics Active Pharmaceutical Ingredient Revenue, 2016-2027
  6.6.2 Brazil Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.6.3 Argentina Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Revenue, 2016-2027
  6.7.2 Turkey Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.7.3 Israel Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.7.4 Saudi Arabia Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027
  6.7.5 UAE Antibiotics Active Pharmaceutical Ingredient Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Sandoz International
  7.1.1 Sandoz International Corporate Summary
  7.1.2 Sandoz International Business Overview
  7.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.1.4 Sandoz International Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.1.5 Sandoz International Key News
7.2 Centrient Pharmaceuticals
  7.2.1 Centrient Pharmaceuticals Corporate Summary
  7.2.2 Centrient Pharmaceuticals Business Overview
  7.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.2.4 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.2.5 Centrient Pharmaceuticals Key News
7.3 CordenPharma International
  7.3.1 CordenPharma International Corporate Summary
  7.3.2 CordenPharma International Business Overview
  7.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.3.4 CordenPharma International Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.3.5 CordenPharma International Key News
7.4 ACS DOBFAR
  7.4.1 ACS DOBFAR Corporate Summary
  7.4.2 ACS DOBFAR Business Overview
  7.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.4.4 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.4.5 ACS DOBFAR Key News
7.5 Nanjing Dorra Pharmaceutical Technology
  7.5.1 Nanjing Dorra Pharmaceutical Technology Corporate Summary
  7.5.2 Nanjing Dorra Pharmaceutical Technology Business Overview
  7.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.5.4 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.5.5 Nanjing Dorra Pharmaceutical Technology Key News
7.6 DAEWOONG PHARMACEUTICAL
  7.6.1 DAEWOONG PHARMACEUTICAL Corporate Summary
  7.6.2 DAEWOONG PHARMACEUTICAL Business Overview
  7.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.6.4 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.6.5 DAEWOONG PHARMACEUTICAL Key News
7.7 Parabolic Drugs
  7.7.1 Parabolic Drugs Corporate Summary
  7.7.2 Parabolic Drugs Business Overview
  7.7.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.4.4 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.7.5 Parabolic Drugs Key News
7.8 Penam Laboratories
  7.8.1 Penam Laboratories Corporate Summary
  7.8.2 Penam Laboratories Business Overview
  7.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.8.4 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.8.5 Penam Laboratories Key News
7.9 ASIATIC DRUGS & PHARMACEUTICALS
  7.9.1 ASIATIC DRUGS & PHARMACEUTICALS Corporate Summary
  7.9.2 ASIATIC DRUGS & PHARMACEUTICALS Business Overview
  7.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.9.4 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.9.5 ASIATIC DRUGS & PHARMACEUTICALS Key News
7.10 Fresenius Kabi
  7.10.1 Fresenius Kabi Corporate Summary
  7.10.2 Fresenius Kabi Business Overview
  7.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.10.4 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.10.5 Fresenius Kabi Key News
7.11 The United Laboratories International Holdings
  7.11.1 The United Laboratories International Holdings Corporate Summary
  7.11.2 The United Laboratories International Holdings Business Overview
  7.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.11.4 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.11.5 The United Laboratories International Holdings Key News
7.12 Aurobindo Pharma Limited
  7.12.1 Aurobindo Pharma Limited Corporate Summary
  7.12.2 Aurobindo Pharma Limited Business Overview
  7.12.3 Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.12.4 Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.12.5 Aurobindo Pharma Limited Key News
7.13 Unimark Remedies
  7.13.1 Unimark Remedies Corporate Summary
  7.13.2 Unimark Remedies Business Overview
  7.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.13.4 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.13.5 Unimark Remedies Key News
7.14 Savior Lifetec
  7.14.1 Savior Lifetec Corporate Summary
  7.14.2 Savior Lifetec Business Overview
  7.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Major Product Offerings
  7.14.4 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Revenue in Global (2016-2021)
  7.14.5 Savior Lifetec Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antibiotics Active Pharmaceutical Ingredient Market Opportunities & Trends in Global Market
Table 2. Antibiotics Active Pharmaceutical Ingredient Market Drivers in Global Market
Table 3. Antibiotics Active Pharmaceutical Ingredient Market Restraints in Global Market
Table 4. Key Players of Antibiotics Active Pharmaceutical Ingredient in Global Market
Table 5. Top Antibiotics Active Pharmaceutical Ingredient Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Antibiotics Active Pharmaceutical Ingredient Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Antibiotics Active Pharmaceutical Ingredient Revenue Share by Companies, 2016-2021
Table 8. Global Companies Antibiotics Active Pharmaceutical Ingredient Product Type
Table 9. List of Global Tier 1 Antibiotics Active Pharmaceutical Ingredient Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibiotics Active Pharmaceutical Ingredient Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Antibiotics Active Pharmaceutical Ingredient Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Antibiotics Active Pharmaceutical Ingredient Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Antibiotics Active Pharmaceutical Ingredient Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Antibiotics Active Pharmaceutical Ingredient Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022-2027
Table 30. Sandoz International Corporate Summary
Table 31. Sandoz International Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 32. Sandoz International Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 33. Centrient Pharmaceuticals Corporate Summary
Table 34. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 35. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 36. CordenPharma International Corporate Summary
Table 37. CordenPharma International Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 38. CordenPharma International Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 39. ACS DOBFAR Corporate Summary
Table 40. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 41. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 42. Nanjing Dorra Pharmaceutical Technology Corporate Summary
Table 43. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 44. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 45. DAEWOONG PHARMACEUTICAL Corporate Summary
Table 46. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 47. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 48. Parabolic Drugs Corporate Summary
Table 49. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 50. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 51. Penam Laboratories Corporate Summary
Table 52. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 53. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 54. ASIATIC DRUGS & PHARMACEUTICALS Corporate Summary
Table 55. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 56. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 57. Fresenius Kabi Corporate Summary
Table 58. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 59. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 60. The United Laboratories International Holdings Corporate Summary
Table 61. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 62. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 63. Aurobindo Pharma Limited Corporate Summary
Table 64. Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 65. Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 66. Unimark Remedies Corporate Summary
Table 67. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 68. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)
Table 69. Savior Lifetec Corporate Summary
Table 70. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Product Offerings
Table 71. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Antibiotics Active Pharmaceutical Ingredient Segment by Type
Figure 2. Antibiotics Active Pharmaceutical Ingredient Segment by Application
Figure 3. Global Antibiotics Active Pharmaceutical Ingredient Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Antibiotics Active Pharmaceutical Ingredient Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Antibiotics Active Pharmaceutical Ingredient Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antibiotics Active Pharmaceutical Ingredient Revenue in 2020
Figure 8. By Type - Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027
Figure 9. By Application - Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027
Figure 10. By Region - Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027
Figure 11. By Country - North America Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027
Figure 12. US Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027
Figure 16. Germany Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 17. France Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027
Figure 24. China Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 28. India Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027
Figure 30. Brazil Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Revenue Market Share, 2016-2027
Figure 33. Turkey Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Antibiotics Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2016-2027
Figure 37. Sandoz International Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. CordenPharma International Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Revenue Year Over Year Growth (US$, Mn) & (2016-2021)